直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

In re Llanos

Abbott Vascular

Cordis Corp.

Member of team that represented Abbott Vascular in inter partes reexaminations related to biocompatible materials for medical devices.

Abbott Vascular v. Cordis Corp., Reexamination Nos. 95/000,552, 95/000,542, USPTO, Judge Jones

Related Practices

Patent Office Invalidation Proceedings

Ex Parte Reexamination (EPR)

Related Industries

Life Sciences

Medical Device and Diagnostics

Biologics

Related Experiences

Precision BioSciences v. Institut Pasteur

Institut Pasteur

Apple, Inc. v. VirnetX, Inc. 

VirnetX, Inc.

 POSCO v. Nippon Steel

POSCO

In re Osslund 

In re Bayer*

John William Bayer

Cisco Systems, Inc. v. VirnetX, Inc. 

VirnetX, Inc.

In re Fetzima

Allergan USA, Inc.; Pierre Fabre Medicament SAS

In re: Posco

POSCO

Ex parte reexamination on behalf of third-party results in PTO rejection of claims

Financial Fusion

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP